Cohort Study: Donepezil Associated with Increased Risk of Rhabdomyolysis

Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study – Canadian Medical Association Journal (free)

Commentaries: Commonly used drug for Alzheimer’s disease doubles risk of hospitalization – Canadian Medical Association Journal (free) Study: Common Alzheimer’s disease drug doubles hospitalization risk – UPI (free) AND Rhabdomyolysis risk with donepezil double that of other AD meds – OnMedica (free)